NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for placebo-controlled


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on psychopharmacology described by T.P. Freeman et al
2009 NOV 28 -- "Ketamine has previously been shown to induce delusion-like or referential beliefs, both acutely in healthy volunteers and naturalistically among nonintoxicated users of the drug. Delusions are theoretically underpinned by increased......
Subject: Psychopharmacology
Price: $3.00
*
Despite some benefit, drug ads can be harmful to your health
2009 NOV 28 -- While the debate over prescription drug advertising persists, a new study released online in the American Journal of Public Health offers guidelines for improving drug ads in order to minimize potential harm and maximize benefits. The study......
Subject: IQ Solutions, Inc.
Price: $3.00
*
Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations
2009 NOV 25 ... announced merger into Ligand. Aplindore This Phase 2 RLS study was a randomized, placebo-controlled, double-blind, multi-center, parallel-group study designed to assess the efficacy, ...
Subject: Neurogen Corporation
Price: $3.00
*
New findings from University of Alabama in the area of science published
2009 NOV 26 ... in the dietary management of knee osteoarthritis. The 12-week, randomized, double-blind, placebo-controlled trial in an academic medical center enrolled 59 patients with moderate osteoarthritis of ...
Subject: Science
Price: $3.00
*
New science study findings reported from Harokopio University
2009 NOV 26 ... its antioxidant effects if consumed on a daily basis by healthy subjects. In this placebo-controlled clinical trial, 63 subjects were recruited for a 1-month nutritional intervention. ...
Subject: Science
Price: $3.00
*
New surgery findings from Shriners Hospital for Children described
2009 NOV 25 -- "Recovery from a massive burn is characterized by catabolic and hypermetabolic responses that persist up to 2 years and imp air rehabilitation and reintegration The objective of this study was to determine the effects of long-term treatment with......
Subject: Surgery
Price: $3.00
*
Popular anti-platelet therapy reduces risk of cardiovascular events in men and women
2009 NOV 29 ... 30 percent of whom were women. Lead investigators of the five double-blinded, randomized placebo-controlled trials shared original study data with authors.Clopidogrel works to disrupt ...
Subject: American College of Cardiology
Price: $3.00
*
Research in the area of pediatrics reported from Bristol-Myers Squibb Company
2009 NOV 28 ... aripiprazole (5, 10, or 15 mg/day) or placebo in this 8-week double-blind, randomized, placebo-controlled, parallel-group study.""Efficacy was evaluated using the caregiver-rated ...
Subject: Pediatrics
Price: $3.00
*
Studies from Children's Hospital in the area of life sciences described
2009 NOV 26 ... with the intention of preventing urinary tract infection, but adequately powered, placebo-controlled trials regarding efficacy are lacking. This study from four Australian centers examined ...
Subject: Life Sciences
Price: $3.00
*
Studies from H. Amagase and co-researchers in the area of science published
2009 NOV 26 ... the amount traditionally used, or placebo for 30 days in a randomized, double-blind, placebo-controlled clinical study in 60 older healthy adults (55-72 years old)," investigators in the ...
Subject: Science
Price: $3.00
*
Studies from Harokopio University yield new information about food microbiology
2009 NOV 26 ... According to a study from Athens, Greece, "In this randomized, double-blinded, placebo-controlled clinical study we aimed to evaluate the in vivo prebiotic effects of a functional food ...
Subject: Food Microbiology
Price: $3.00
*
Study data from X.Q. Luo and colleagues update understanding of pharmaceuticals
2009 NOV 23 -- According to a study from Beijing, People's Republic of China, "A sensitive LC method with pre-column fluorescence derivatization using 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate has been developed for the determination of defibrase from......
Subject: Pharmaceuticals
Price: $3.00
*
Study data from Y. Tominaga et al provide new insights into surgery
2009 NOV 25 -- "Secondary hyperparathyroidsm (2HPT) is a common complication in hemodialysis patients associated with morbidity and sometimes mortality. The majority of patients with 2HPT can be managed by medical treatment," investigators in Nagoya, Japan......
Subject: Surgery
Price: $3.00
*
Study results from University of California, Medical Department update understanding of breast cancer
2009 NOV 23 -- "Estrogen plus progestin therapy increases breast cancer incidence and breast tenderness. Whether breast tenderness during estrogen plus progestin therapy is associated with breast cancer risk is uncertain," scientists writing in the journal......
Subject: Breast Cancer
Price: $3.00
*
Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents
2009 NOV 23 ... or 505(b)(2) application, should conduct pre-clinical testing as well as full-scale, placebo-controlled clinical trials with measured clinical endpoints in MS patients to establish safety, ...
Subject: Teva Pharmaceutical Industries Ltd.
Price: $3.00
*
The narrow line between love and jealousy
2009 NOV 23 -- A new study carried out at the University of Haifa has found that the hormone oxytocin, the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating.......
Subject: University of Haifa
Price: $3.00
*
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
2009 NOV 23 ... infectious diseases, announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers. The two studies, a ...
Subject: Pharmacokinetics
Price: $3.00
*
University of Calgary details research in syncope
2009 NOV 23 ... effectiveness in preventing syncope. The Prevention of Syncope Trial was a randomized, placebo-controlled, double-blind, multinational, clinical trial that tested the hypothesis that metoprolol ...
Subject: Syncope
Price: $3.00
*
University of Pittsburgh, Western Psychiatric Institute details research in cancer epidemiology
2009 NOV 23 -- "Genes coding for nicotinic acetylcholine receptors may influence response to nicotine replacement therapy for smoking cessation. We examined the association of a 3' untranslated region polymorphism (rs2072661) in the nicotinic acetylcholine......
Subject: Cancer Epidemiology
Price: $3.00
*
Vacationing in Thailand over Greece? That's the dopamine talking
2009 NOV 24 -- People constantly make complex decisions, from the more mundane-which restaurant to go to for dinner or which movie to go see-to the more profound-whether to have kids or not. Now, a new study published online on November 12th in Current Biology,......
Subject: Research
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login